DEPLOYDatabase

Company

Zepp Health (Amazfit)

Budget-tier smart-wearable maker (NYSE: ZEPP; formerly Huami; founder Wang Huang) behind the Amazfit brand + Zepp app/AI (Zepp Flow/Coach/Aura);…

Track Zepp Health (Amazfit)Get notified of verified changes
Founded
2013
HQ
Beijing, China
Status
public (NYSE: ZEPP)

Models

1

Overview

Budget-tier smart-wearable maker (NYSE: ZEPP; formerly Huami; founder Wang Huang) behind the Amazfit brand + Zepp app/AI (Zepp Flow/Coach/Aura); general-wellness (no FDA-cleared ECG); 200M+ devices shipped.

Verified record

Verified deployments
None on file
Active incidents
1 incident on file

DEPLOY Intelligence

Market intelligence for physical AI

Analyst-grade signals, competitive tracking, and investment context across the global physical AI landscape. Launching 2026.

Key facts

Product

Amazfit devices (Balance/Active/T-Rex/Helio Ring) + Zepp AI (Flow/Coach/Aura); general-wellness.

Scale

Budget-tier at scale: 200M+ devices, 53M users (company-reported); 2025 revenue $258.9M +41.8%.

Stock listing

NYSE: ZEPP

Former name

Huami

Founder

Wang Huang

Regulatory status

No FDA-cleared ECG

Data & sources

Press releases

3

3 sources backing this record.View all →

Current platform

Amazfit (Balance / Active / T-Rex / Helio)

Zepp Health Corporation (NYSE: ZEPP), the company formerly known as Huami and renamed in February 2021 under founder and chief executive Wang Huang, makes the Amazfit line of budget-tier biometric smartwatches, bands, and rings, recorded in the biometric form factor with the company as Zepp Health, the Amazfit consumer brand as the device line, and the Zepp app and its AI features as model attributes; its historical manufacturing of the Xiaomi Mi Band is an original-design-manufacturer note rather than a separate model line. The Amazfit line spans the Balance, Active, T-Rex, Bip, Cheetah, and Falcon devices plus the Helio Ring and Strap, pairing heart-rate, blood-oxygen, sleep, and stress sensing with genuine AI augmentation including the GPT-backed Zepp Flow voice assistant, the adaptive Zepp Coach, and the Zepp Aura AI sleep features. On FDA status, Amazfit devices are general-wellness and not FDA-cleared for medical features, with no FDA-cleared ECG app and atrial-fibrillation capability that is PPG-based rather than a cleared ECG path, and although a 2025 meta-analysis reported strong real-world atrial-fibrillation diagnostic accuracy for an Amazfit PPG system, that is published-study validation rather than FDA clearance, a distinction the registry keeps strictly separate. The company illustrates the scale-versus-validation framework, with high volume and real AI breadth but lighter clinical and regulatory validation than Apple or Withings: it reports more than 200 million devices shipped cumulatively to more than 53 million users across 150-plus countries and 2025 revenue of $258.9 million, up 41.8 percent year over year. Its claim to be the first to fully integrate AI into smartwatches is marketing rather than independently verified, its cumulative unit and user figures are company-reported, and its heart-health framing rides on PPG and a study rather than FDA clearance.

biometricView model →

Zepp Health (Amazfit) on the deployment map

Where Zepp Health (Amazfit)'s robots are verified operating. Explore the deployment map by place and type.

Explainers

Plain-language answers to the questions people ask about Zepp Health (Amazfit), from DEPLOY’s explainer library. Each is written in the language of the question and cross-checked against this registry.

  • What is Zepp Health?

    [Zepp Health](https://registry.deploy.report/companies/zepp-health) (formerly Huami) is a Chinese-headquartered consumer biometric maker behind the [Amazfit](https://registry.deploy.report/models/amazfit) smartwatch + band product line. Per registry verification: company entity at /companies/zepp-health; Amazfit product line at /models/amazfit (line-level slug covering the broader Amazfit watch + band portfolio). Per general industry context (cap-flagged at primary-source verification depth): Zepp Health is publicly-traded (NYSE: ZEPP); operates Amazfit consumer biometric brand at consumer-retail pricing tier; positioned within the biometric cluster's smartwatch + band cohort alongside Apple Watch + Pixel Watch + Fitbit + Samsung Galaxy Watch + Garmin + Whoop. Per [DEPLOY's biometric cluster framework](/explainers/biometric): specific Zepp Health product feature claims + FDA clearance posture + commercial deployment scope + AI-substance tier + funding state operate at lower verification posture pending primary-source confirmation. Cohort positioning: Chinese-headquartered consumer biometric maker entry within the biometric cluster's smartwatch + band cohort with cap-flagged claim depth pending primary-source verification.

  • How does DEPLOY track the Amazfit Helio Ring ITC investigation?

    The Amazfit Helio Ring ITC investigation operates as a canonical worked example of incident-tracking at ITC patent-trade primary-source verification depth. Per Agent A IncidentStatusEvent substrate at [/incidents/amazfit-helio-ring-oura-itc-investigation-2025](https://registry.deploy.report/incidents/amazfit-helio-ring-oura-itc-investigation-2025): the U.S. International Trade Commission (ITC) is investigating the Amazfit Helio Ring (Zepp Health subsidiary product) under a Section 337 patent investigation initiated by Oura Health in 2025. The investigation operates at ITC patent-trade primary-source verification depth (tier 3 primary-government-record sub-tier per [DEPLOY's 9-tier source-quality rubric](/explainers/source-quality-rubric)); the sub-tier is structurally distinct from the CPSC consumer-product-safety sub-tier exercised in the [Fitbit Ionic burn recall narrative](/explainers/how-deploy-tracks-the-fitbit-ionic-burn-recall) + the FDA medical-device sub-tier exercised in the [Withings ScanWatch ECG recall narrative](/explainers/how-deploy-tracks-the-withings-scanwatch-ecg-recall). EDITORIAL THROUGHLINE: pairs with the broader Oura '178 patent ITC family with opposite outcomes. [Ultrahuman](/explainers/what-is-ultrahuman) excluded (US blocked Oct 21 2025 → restored Mar 24 2026 via Ring Pro unibody redesign) + [RingConn](/explainers/what-is-ringconn) licensed-and-selling (settled-licensed cleanly with Oura on '178 patent; NOT banned per Agent A correction) + now Amazfit Helio Ring under investigation operating at active-investigation verification posture. The three biometric incident narratives together demonstrate framework-in-action across regulatory-source-tier diversity within a single cohort. This piece documents the catch as framework-in-action worked example: ITC patent-trade incident-tracking discipline + active-investigation verification posture + canonical-worked-example-pair architecture compounding across the Oura ITC family operating at editorial-anchor depth.

Current leadership (3)

Founders (1)

Safety record

1 incident on record (1 moderate). Most recent: Dec 2025.

moderate
1

Most recent: Dec 2025

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Full safety record: incidents, sourcing, and exposure data →

Incidents affecting Zepp Health (Amazfit) (1)

Includes incidents linked directly to this company, to its models, or to deployments of its models or under its operation. Retracted incidents are excluded from this view but remain reachable at their canonical URLs.

Recent coverage

Zepp Health (Amazfit) in third-party press

Peer companies